Skip to content

Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care

Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03734107
Enrollment
52
Registered
2018-11-07
Start date
2018-11-06
Completion date
2026-01-02
Last updated
2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Keywords

transition to adult medical care, adolescents and young adults, health communication, adherence, type 1 diabetes

Brief summary

Adolescents and young adults (AYAs; ages 17-23) with type 1 diabetes are at high risk for negative health outcomes, including poor glycemic control and disengagement from the health care system. The deterioration of glycemic control occurs in parallel with the assumption of independent self-care skills and preparation for adult diabetes care. Effective communication between AYAs and health care providers may be a critical contributor to diabetes self-care skills during the transition to adult diabetes care and related glycemic control. This research will attempt to better prepare adolescents and young adults for adult diabetes care by delivering innovative intervention content focused on both health communication skills and transition readiness skills. The investigators aim to leverage innovative technologies to improve developmentally-appropriate communication skills related to planning for clinic visits, disclosing and discussing diabetes-related concerns, and optimizing glucose data review in preparation for adult diabetes care. Adolescents and young adults with type 1 diabetes (ages 17-23) who are planning to transition to adult diabetes care within the next 6-8 months will be enrolled in the study and randomized to either the intervention group or a standard care control group. Medical, communication and psychosocial data (including A1c, glucose monitoring frequency, communication quality, health care engagement, depressive symptoms) will be collected from adolescent and young adult participants and health care providers at baseline and two follow-up time points, approximately 4 months post-baseline and approximately 8-12 months post-baseline after the transfer to adult diabetes care. This intervention has the potential to improve diabetes self-care skills, including engagement with health care providers, and glycemic control in AYAs with type 1 diabetes during the vulnerable period of transfer to adult diabetes care. The results of this work will inform best practices for the transition to adult diabetes care and can be translated into clinical care.

Detailed description

Research Design and Methods Overview of Study Design & Procedure. The aim of this randomized controlled trial (RCT) is to determine the efficacy of a behavioral intervention targeting health communication skills and diabetes self-management skills in preparation for the transfer to adult diabetes care, compared to usual care. The intervention, Plan, Reflect, and Engage with Providers for Diabetes Care (PREP-DC), consists of three intervention sessions with a study interventionist, paired text messages, and access to glucose management software. It is expected that adolescents and young adults allocated to the intervention condition (PREP-DC) will evidence: 1) better glycemic control (lower A1c); 2) shorter gap in time between the last visit in pediatric diabetes care and the first visit in adult diabetes care; 3) better diabetes management (better adherence to the diabetes regimen); 4) fewer reported complications (e.g. hospitalizations and emergency department visits). A total of 100 adolescent and young adult participants (ages 17-23) will be randomly allocated in a 1:1 ratio to either the PREP-DC intervention condition (n=50) or usual care (n=50; standard care comparison condition): all participants receive standard resources for transition to adult diabetes care as part of usual care in both conditions. Participants include 100 adolescents and young adults (ages 17-23) diagnosed with T1D for at least one year (anticipated 50% female) seen for diabetes care at Children's National Medical Center (CNMC) in Washington, DC. Eligible participants will self-identify as planning to transfer to adult diabetes care within the upcoming 6-8 months. Participants in the PREP-DC intervention will complete three intervention sessions with study team members over a 3 month period (approximately 1 intervention session per month). Two sessions will be with a trained study interventionist focusing on communication with health care providers and preparation for medical visits and adult diabetes care. One session will be with a certified diabetes education focusing on problem-solving using glucose data and glucose data review. PREP-DC intervention participants will also receive text messages (3-4 messages/week) for the 3 month intervention period supporting intervention content. Participants also will be given information about accessing glucose management software specific to their diabetes devices and related study resources (e.g. study website). Participants are evaluated at baseline (pre-randomization to intervention or standard care comparison group) and follow-up (approximately 4 months post-baseline and approximately 8-12 months post-baseline after the transition to adult diabetes care).

Interventions

BEHAVIORALPlan, Reflect, and Engage with Providers for Diabetes Care

Behavioral intervention designed to improve health communication skills and readiness for adult diabetes care

Sponsors

Children's National Research Institute
Lead SponsorOTHER
American Diabetes Association
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Participants are randomized in a 1:1 ratio to the intervention group or standard care comparison group

Eligibility

Sex/Gender
ALL
Age
17 Years to 23 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with type1 diabetes for ≥ 1 year * Able to adequately understand, speak, and read English to benefit from participation * Ready and consistent text messaging access to participate * Within 6-8 months of planned transfer to adult diabetes care

Exclusion criteria

* Other life-threatening disease (e.g. cancer) or major psychiatric disorder (e.g. schizophrenia) that significantly limits participation * Pervasive developmental disorder that significantly limits participation

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin A1c8 months post-baselinepercentage of glycated hemoglobin (Hemoglobin A1c)
Number of Days to First Adult Diabetes Care Visit8 months post-baselineNumber of days between the last visit in pediatric diabetes care and the first visit in adult diabetes care (reported as number of days).
Adherence to the Diabetes Care Regimen8 months post-baselineParticipant report on the Diabetes Management Questionnaire (DMQ), a self-report measure of adherence to the diabetes care regimen. The DMQ consists of 20 items scored on a 0-4 Likert Scale. The measure has a total score; the mean score on all items is calculated and multiplied by 25 to arrive at the total score (possible range 0-100). A higher score indicates greater adherence to diabetes management.
Diabetes-related Hospitalizations8 months post-baselineParticipant report and medical record review of reported diabetes-related hospitalizations for the duration of the study period. The total number of diabetes-related emergency department visits/hospitalizations is summed.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRandi Streisand, PhD

Children's National Research Institute

Participant flow

Pre-assignment details

Letters were sent to 187 adolescents and young adults. Fifty-two participants completed all baseline procedures and were enrolled and randomized.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
51 Participants
Age, Continuous20.68 years
STANDARD_DEVIATION 1.1
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
25 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
9 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
25 Participants
Region of Enrollment
United States
26 participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 260 / 26
other
Total, other adverse events
0 / 260 / 26
serious
Total, serious adverse events
0 / 260 / 26

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026